Clinical characteristics of non-alcoholic fatty liver disease in Chinese adult hypopituitary patients

doi:10.3748/wjg.v25.i14.1741

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 25, Issue 14

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (7951)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-1) series, Tables (1-3) series.

Item

Count

PDF

424

WORD

208

HTML

4618

Figures (1-1)

149

Tables (1-3)

149

Sum=5548

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

859

Download

1544

Sum=2403

Apr 14, 2019 (publication date) through Apr 18, 2024

Times Cited of This Article

Times Cited (15)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Gastroenterol. Apr 14, 2019; 25(14): 1741-1752
Published online Apr 14, 2019. doi: 10.3748/wjg.v25.i14.1741

Table 3 Liver function including liver enzymes, routine blood tests, and coagulation function tests in our patients

Index		NAFLD (-) (n = 23)	NAFLD (+)
Index		NAFLD (-) (n = 23)	NAFLD (n = 20)	Cirrhosis (n = 7)
Liver enzymes	ALT (U/L)	26.0 (20.0-41.0)	35.0 (27.3-81.8)	23.0 (19.0-59.0)
	ALB (g/L)	46.8 ± 3.5^a	47.7 ± 3.0^a	49.6 ± 4.6
	TBil (μmol/L)	8.7 (6.9-14.4)^b	12.3 (8.0-17.1)^a	13.2 (9.9-15.9)
	DBil (μmol/L)	2.6 (2.2-4.4)	3.4 (2.6-5.5)	4.4 (3.2-5.1)
	GGT (U/L)	23.0 (16.0-33.0)^a	52.0 (29.0-77.0)	52.0 (23.0-141.0)
	ALP (U/L)	77.0 (60.5-122.5)	82.0 (69.0-92.0)	71.0 (62.0-117.0)
	AST (U/L)	28.0 (22.5-38.5)	36.0 (26.0-55.0)	26.0 (20.0-59.0)
	TBA (μmol/L)	2.90 (1.35-3.25)	3.60 (2.30-7.00)	3.60 (1.30-9.10)
	LD (U/L)	233.9 ± 54.8	227.6 ± 41.4	215.3 ± 60.8
Routine blood tests	WBC (×10⁹/L)	6.53 ± 2.61^a	6.32 ± 1.71^a	4.02 ± 1.14
	NEUT# (×10⁹/L)	3.65 ± 1.90^b	3.44 ± 1.24^a	1.75 ± 0.30
	PLT (×10⁹/L)	250.5 ± 81.1^c	273.0 ± 90.1^c	91.1 ± 53.3
Coagulation function tests	PT (s)	12.11 ± 1.06^c	11.87 ± 1.01^c	15.43 ± 2.24
	PT% (%)	87.3 ± 8.8^c	94.3 ± 14.9^c	62.6 ± 12.1
	INR	1.05 ± 0.08^c	1.01 ± 0.10^c	1.33 ± 0.17
	FgB (g/L)	2.97 ± 0.78^b	3.09 ± 0.81^b	1.89 ± 0.59
	APTT (s)	31.35 (25.70-35.15)	28.45 (25.30-38.33)	33.50 (30.48-41.58)
	TT (s)	18.34 ± 0.97^b	17.82 ± 0.94^c	19.75 ± 1.08

^aP < 0.05 vs the cirrhosis group.

^bP < 0.01 vs the cirrhosis group.

^cP < 0.001 vs the cirrhosis group.

NAFLD: Non-alcoholic fatty liver disease; ALT: Alanine aminotransferase; ALB: Albumin; TBil: Total bilirubin; DBil: Direct bilirubin; GGT: γ-glutamyltransferase; ALP: Alkaline phosphatase; AST: Aspartate aminotransferase; TBA: Total bile acid; LD: Lactic dehydrogenase; WBC: White blood cells; NEUT: Neutrophil granulocyte; PLT: Blood platelet; PT: Prothrombin time; INR: International normalized ratio; FgB: Fibrinogen; APTT: Activated partial thromboplastin time; TT: Thrombin time.

Citation: Yuan XX, Zhu HJ, Pan H, Chen S, Liu ZY, Li Y, Wang LJ, Lu L, Yang HB, Gong FY. Clinical characteristics of non-alcoholic fatty liver disease in Chinese adult hypopituitary patients. World J Gastroenterol 2019; 25(14): 1741-1752
URL: https://www.wjgnet.com/1007-9327/full/v25/i14/1741.htm
DOI: https://dx.doi.org/10.3748/wjg.v25.i14.1741